Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu, Drew M. Pardoll, Richard Jove
Nature reviews. Cancer (2009) Vol. 9, Iss. 11, pp. 798-809
Open Access | Times Cited: 3931

Showing 1-25 of 3931 citing articles:

Immunity, Inflammation, and Cancer
Sergei I. Grivennikov, Florian R. Greten, Michael Karin
Cell (2010) Vol. 140, Iss. 6, pp. 883-899
Open Access | Times Cited: 9726
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich, Suzanne Ostrand‐Rosenberg, Vincenzo Bronte
Nature reviews. Immunology (2012) Vol. 12, Iss. 4, pp. 253-268
Open Access | Times Cited: 3272
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten, Sergei I. Grivennikov
Immunity (2019) Vol. 51, Iss. 1, pp. 27-41
Open Access | Times Cited: 2745
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko, Abhishek D. Garg, Agnieszka Kaczmarek, et al.
Nature reviews. Cancer (2012) Vol. 12, Iss. 12, pp. 860-875
Closed Access | Times Cited: 2516
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson, Rachel A. O’Keefe, Jennifer R. Grandis
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 4, pp. 234-248
Open Access | Times Cited: 2296
Diabetes and Cancer
Edward L. Giovannucci, David M. Harlan, Michael C. Archer, et al.
Diabetes Care (2010) Vol. 33, Iss. 7, pp. 1674-1685
Open Access | Times Cited: 2091
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu, Heehyoung Lee, Andreas Herrmann, et al.
Nature reviews. Cancer (2014) Vol. 14, Iss. 11, pp. 736-746
Closed Access | Times Cited: 1896
Inflammation and Colon Cancer
Janoš Terzić, Sergei I. Grivennikov, Eliad Karin, et al.
Gastroenterology (2010) Vol. 138, Iss. 6, pp. 2101-2114.e5
Open Access | Times Cited: 1874
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
Eran Elinav, Roni Nowarski, Christoph A. Thaiss, et al.
Nature reviews. Cancer (2013) Vol. 13, Iss. 11, pp. 759-771
Closed Access | Times Cited: 1763
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1577
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang, Pengfei Shi, Gaichao Zhao, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 1499
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
Masaki Imai, Tokiko Watanabe, Masato Hatta, et al.
Nature (2012) Vol. 486, Iss. 7403, pp. 420-428
Open Access | Times Cited: 1469
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1413
The JAK/STAT signaling pathway: from bench to clinic
Xiaoyi Hu, Jing Li, Maorong Fu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1408
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O’Shea, Daniella M. Schwartz, Alejandro V. Villarino, et al.
Annual Review of Medicine (2015) Vol. 66, Iss. 1, pp. 311-328
Open Access | Times Cited: 1317
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben‐Neriah, Michael Karin
Nature Immunology (2011) Vol. 12, Iss. 8, pp. 715-723
Closed Access | Times Cited: 1314
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin, Jian‐Xin Xu, Huiyin Lan
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 1157
Cancer and the microbiota
Wendy S. Garrett
Science (2015) Vol. 348, Iss. 6230, pp. 80-86
Open Access | Times Cited: 1091
Fever and the thermal regulation of immunity: the immune system feels the heat
Sharon S. Evans, Elizabeth A. Repasky, Daniel T. Fisher
Nature reviews. Immunology (2015) Vol. 15, Iss. 6, pp. 335-349
Open Access | Times Cited: 1035
Diabetes and Cancer: A Consensus Report
Edward L. Giovannucci, David M. Harlan, Michael C. Archer, et al.
CA A Cancer Journal for Clinicians (2010) Vol. 60, Iss. 4, pp. 207-221
Open Access | Times Cited: 1020
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flávia Castro, Ana Patrícia Cardoso, Raquel M. Gonçalves, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 1017
IL-6 in inflammation, autoimmunity and cancer
Toshio Hirano
International Immunology (2020) Vol. 33, Iss. 3, pp. 127-148
Open Access | Times Cited: 865
STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
Dimitrios Iliopoulos, Savina Jaeger, Heather A. Hirsch, et al.
Molecular Cell (2010) Vol. 39, Iss. 4, pp. 493-506
Open Access | Times Cited: 807
JAKs and STATs in Immunity, Immunodeficiency, and Cancer
John J. O’Shea, Steven M. Holland, Louis M. Staudt
New England Journal of Medicine (2013) Vol. 368, Iss. 2, pp. 161-170
Open Access | Times Cited: 806
Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
Marina Lesina, Magdalena U. Kurkowski, Katharina Ludes, et al.
Cancer Cell (2011) Vol. 19, Iss. 4, pp. 456-469
Open Access | Times Cited: 805
Page 1 - Next Page

Scroll to top